Modulation of the Bile Acid Enterohepatic Cycle by Intestinal Microbiota Alleviates Alcohol Liver Disease
Authors:
- Dragos CiocanDCDragos Ciocan
- Madeleine SpatzMSMadeleine Spatz
- Nicolas TrainelNTNicolas Trainel
- Kévin HardonnièreKHKévin Hardonnière
- Séverine DomenichiniSDSéverine Domenichini
- Françoise Mercier-NoméFMFrançoise Mercier-Nomé
- Aurore DesmonsADAurore Desmons
- Lydie HumbertLHLydie Humbert
- Sylvère DurandSDSylvère Durand
- Guido KroemerGuido Kroemer
- Antonin LamazièreALAntonin Lamazière
- Cindy HugotCHCindy Hugot
Open Access
Abstract
Reshaping the intestinal microbiota by the ingestion of fiber, such as pectin, improves alcohol-induced liver lesions in mice by modulating bacterial metabolites, including indoles, as well as bile acids (BAs). In this context, we aimed to elucidate how oral supplementation of pectin affects BA metabolism in alcohol-challenged mice receiving feces from patients with alcoholic hepatitis. Pectin reduced alcohol liver disease. This beneficial effect correlated with lower BA levels in the plasma and liver but higher levels in the caecum, suggesting that pectin stimulated BA excretion. Pectin modified the overall BA composition, favoring an augmentation in the proportion of hydrophilic forms in the liver, plasma, and gut. This effect was linked to an imbalance between hydrophobic and hydrophilic (less toxic) BAs in the gut. Pectin induced the enrichment of intestinal bacteria harboring genes that encode BA-metabolizing enzymes. The modulation of BA content by pectin inhibited farnesoid X receptor signaling in the ileum and the subsequent upregulation of Cyp7a1 in the liver. Despite an increase in BA synthesis, pectin reduced BA serum levels by promoting their intestinal excretion. In conclusion, pectin alleviates alcohol liver disease by modifying the BA cycle through effects on the intestinal microbiota and enhanced BA excretion.Keywords
This publication has 51 references indexed in Scilit:
- Predictive functional profiling of microbial communities using 16S rRNA marker gene sequencesNature Biotechnology, 2013
- The Potent Bile Acid Sequestrant Colesevelam Is Not Effective in Cholestatic Pruritus: Results of a Double-Blind, Randomized, Placebo-Controlled TrialHepatology, 2010
- Mechanisms underlying the cholesterol-lowering properties of soluble dietary fibre polysaccharidesFood & Function, 2010
- Improved Glycemic Control with Colesevelam Treatment in Patients with Type 2 Diabetes Is Not Directly Associated with Changes in Bile Acid MetabolismHepatology, 2010
- Effect of the Bile Acid Sequestrant Colesevelam on the Pharmacokinetics of Pioglitazone, Repaglinide, Estrogen Estradiol, Norethindrone, Levothyroxine, and GlyburideThe Journal of Clinical Pharmacology, 2010
- Targeting bile-acid signalling for metabolic diseasesNature Reviews Drug Discovery, 2008
- Dietary agents that target gastrointestinal and hepatic handling of bile acids and cholesterolJournal of Clinical Lipidology, 2008
- Bile acids induce energy expenditure by promoting intracellular thyroid hormone activationNature, 2006
- Intestinal steroids in rats are influenced by the structural parameters of pectinThe Journal of Nutritional Biochemistry, 2004
- Regulation of Multidrug Resistance-associated Protein 2 (ABCC2) by the Nuclear Receptors Pregnane X Receptor, Farnesoid X-activated Receptor, and Constitutive Androstane ReceptorJournal of Biological Chemistry, 2002